Raphas Co. Ltd (214260) - Total Liabilities

Latest as of June 2026: ₩40.43 Billion KRW ≈ $27.40 Million USD

Based on the latest financial reports, Raphas Co. Ltd (214260) has total liabilities worth ₩40.43 Billion KRW (≈ $27.40 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Raphas Co. Ltd (214260) asset resilience to evaluate the company's liquid asset resilience ratio.

Raphas Co. Ltd - Total Liabilities Trend (2017–2025)

This chart illustrates how Raphas Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Raphas Co. Ltd's balance sheet.

Raphas Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Raphas Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Grupo Pochteca S.A.B. de C.V MX:POCHTECB	Mexico	MX$4.88 Billion
Ocumetics Technology Corp V:OTC	Canada	CA$6.24 Million
Dongyang Expre KO:084670	Korea	₩101.95 Billion
EstechPharma Co. Ltd KQ:041910	Korea	₩60.00 Billion
Dongwon Metal KO:018500	Korea	₩474.46 Billion
Ensari Deri Gida Sanayi ve Ticaret AS IS:ENSRI	Turkey	TL770.87 Million
Econpile Holdings Bhd KLSE:5253	Malaysia	RM247.59 Million
Goodyear (Thailand) Public Company Limited BK:GYT	Thailand	฿5.19 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Raphas Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Raphas Co. Ltd (214260) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.58	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.59	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Raphas Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Raphas Co. Ltd (2017–2025)

The table below shows the annual total liabilities of Raphas Co. Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩44.36 Billion ≈ $30.06 Million	-5.07%
2024-12-31	₩46.73 Billion ≈ $31.67 Million	-31.37%
2023-12-31	₩68.10 Billion ≈ $46.15 Million	+23.51%
2022-12-31	₩55.13 Billion ≈ $37.36 Million	+21.21%
2021-12-31	₩45.49 Billion ≈ $30.82 Million	+190.71%
2020-12-31	₩15.65 Billion ≈ $10.60 Million	+3.95%
2019-12-31	₩15.05 Billion ≈ $10.20 Million	+4.67%
2018-12-31	₩14.38 Billion ≈ $9.75 Million	+29.90%
2017-12-31	₩11.07 Billion ≈ $7.50 Million	--

About Raphas Co. Ltd

KQ:214260 Korea Biotechnology

Market Cap

$42.74 Million

₩63.06 Billion KRW

Market Cap Rank

#22567 Global

#1460 in Korea

Share Price

₩7500.00

Change (1 day)

-1.06%

52-Week Range

₩6720.00 - ₩15350.00

All Time High

₩75400.00